Bevillinger: TrygFonden: 4.000.000,00 kr. Vilhelm-Pedersens og Hustrus mindelegat: 1.240.000,00 kr. Aarhus Universitet: 450.000,00 kr. Aase og Ejnar Danielsens Fond: 100.000,00 kr. Novo Nordisk: 9.999.928,00 kr. (Stroke biomarker sub-studie) Novo Nordisk: 2.562.153,00 kr. (Stroke biomarker sub-studie) National Institute of Health: 514.253,00 USD (Stroke biomarker sub-studie) Publikationer: Blauenfeldt RA, Hjort N, Gude MF Behrndtz AB, Fisher M, Valentin JB, Kirkegaard H, Johnsen SP, Hess DC, Andersen G. A multicentre, ran- domised, sham-controlled trial on REmote iSchemic conditioning In patients with acute STroke (RESIST) – Rationale and study design . European Stroke Journal. 2019:5(1);94-101. 23
Download PDF fil